Founded in 1988, New England Independent Review Board® (New England IRB) is one of the original independent IRBs established to meet the review needs of sponsors, contract research organizations (CROs), and investigators across the United States. Today, New England IRB is the preferred provider of ethical review services to New England’s fast-growing bio-pharmaceutical industry.
Located in the greater Boston-Cambridge area, New England IRB provides a strong regional presence for high-quality, full-service independent review. For single and multi-site studies spanning all phases of research, New England IRB is the definition of innovation and clinical research leadership in the Northeast.
For over 28 years, New England IRB has provided personalized service to our clients, while maintaining the highest standards of ethical review. At New England IRB, we understand that your needs are unique and we strive to complement your best practices with ethics and integrity.
We offer a single point of contact and give you a dedicated client team that handles your study from submission to renewal.
With two Board review deadlines per week, and protocol decisions communicated within 24 hours of the meeting, our turnaround times are outstanding. Even better – additional sites are reviewed within 24-48 hours of complete submissions.
As a member of the WIRB-Copernicus Group® (WCG™) family of companies, we can reduce study start-up time for the local sites involved in your research, eliminating 45-60 days from your timeline.
We have been fully accredited by the Association for the Accreditation of Human Research Protections Programs® (AAHRPP) since 2003, and are in good standing with FDA.
Through our relationship with WCG, you have access to the largest investigator database in the United States. We can help you to target the most reliable and efficient investigators in every therapeutic area.